Coffee and Breast Cancer: What Is the Connection?

Large pooled analyses consistently show that coffee drinking, on its own, neither meaningfully raises nor lowers the overall risk of breast cancer for most women. The relative risk hovers stubbornly close to 1.0 across dozens of studies, with reductions of just a few percent at most. But that flat average conceals real variation underneath: the relationship shifts depending on tumor type, menopausal status, genetics, and even what a woman does after a diagnosis. Those details matter more than the headline number.

What the Pooled Data Actually Show

Several meta-analyses have combined findings from case-control and cohort studies to measure the overall association between coffee intake and breast cancer risk. When researchers compared the highest coffee drinkers to the lowest, the pooled relative risk came in around 0.96, meaning roughly a 4% lower risk among the heaviest drinkers, a difference that barely reached statistical significance.¹ A more recent meta-analysis looking at dose-response found that for every two additional cups of coffee per day, the risk of breast cancer dropped by about 2%.² That is a real finding, but it is also a tiny one, and within a range that measurement error and confounding could easily explain.

Another meta-analysis focusing on both case-control and cohort designs separately found similar patterns. Case-control studies tended to show slightly stronger protective signals, with about a 2% risk reduction per cup, while cohort studies hovered near zero effect.³ That discrepancy matters because cohort studies, which follow people forward in time, are generally considered more reliable for dietary questions. When the stronger study designs show little or nothing, the overall picture stays weak.

So at the population level, coffee is close to neutral. If you drink it, there is no strong reason to think you are raising your breast cancer risk. If you do not, there is no strong reason to start for cancer prevention alone. The more useful story begins when you break the data apart.

Where the Signal Gets Stronger: Estrogen-Receptor-Negative Tumors

Breast cancers are not all the same. One of the most important distinctions is whether tumor cells carry estrogen receptors. Tumors that lack these receptors, called ER-negative, tend to be harder to treat and have fewer targeted therapy options. Interestingly, the coffee-breast cancer connection looks different depending on which tumor type you examine.

A Swedish case-control study found that women who drank five or more cups of coffee per day had a 57% lower risk of ER-negative breast cancer compared to women who drank one cup or less.⁴ That is a large effect. When the researchers looked at ER-positive tumors, the association was much weaker and not statistically significant. The difference between the two tumor types was itself significant, which suggests this is not just random noise.

A separate analysis reinforced the pattern, reporting that high coffee intake was associated with a roughly 59% reduced risk of ER-negative breast cancer.⁵ The consistency across independent studies is what makes this finding worth paying attention to, though both are observational. No one has run a randomized trial asking thousands of women to drink coffee for decades and then counting tumors. That is realistically never going to happen, so observational data is what we have to work with.

A narrative review synthesizing research across several subtypes concluded that the inverse association between coffee and breast cancer is most convincing for postmenopausal women and for women carrying BRCA1 mutations, while the picture for ER-positive and premenopausal cancers remains unclear.⁶

Menopausal Status Changes the Picture

Whether a woman has gone through menopause appears to matter a lot. The EPIC cohort, one of Europe’s largest prospective nutrition studies, found that caffeinated coffee was linked to about a 10% lower risk of postmenopausal breast cancer among women who drank the most compared with those who drank the least.⁷ No such association was observed for premenopausal breast cancer.

One Norwegian cohort study looking at brewing method and menopausal status found something unexpected: total coffee consumption was associated with a higher risk of premenopausal breast cancer but a lower risk of postmenopausal breast cancer. The postmenopausal reduction was substantial, with about a 40% lower risk among the heaviest drinkers of filtered coffee.⁸ The premenopausal increase did not reach conventional statistical significance, but it raised questions about why the same beverage might push risk in opposite directions depending on hormonal context.

This divergence is one reason why blanket statements about coffee and breast cancer are misleading. The experience of a 35-year-old woman and a 65-year-old woman may genuinely differ.

How Coffee Might Influence Breast Cancer Biology

Coffee is not just caffeine dissolved in hot water. A standard cup contains hundreds of bioactive compounds, and several of them have plausible mechanisms for affecting cancer risk. The research on these mechanisms is mostly from lab studies and hormone-measurement work in humans, so the gap between “biologically plausible” and “proven to matter in real people” is wide. Still, the pathways are worth understanding because they help explain why the epidemiological patterns look the way they do.

Hormones and Sex Hormone-Binding Globulin

One well-studied pathway involves sex hormone-binding globulin, known as SHBG. This protein binds to estrogen and testosterone in the bloodstream, effectively reducing how much free hormone is available to stimulate tissue growth. Higher SHBG levels generally mean less free estrogen circulating, and lower free estrogen has been linked to lower breast cancer risk. A study of postmenopausal women found that those drinking four or more cups of caffeinated coffee a day had meaningfully higher SHBG levels than nondrinkers.⁹ Decaffeinated coffee did not show the same effect, suggesting caffeine itself may be driving the SHBG increase.

A randomized trial tested this more carefully by assigning people to drink caffeinated coffee, decaffeinated coffee, or no coffee for eight weeks. By the end, the differences in SHBG were not significant, though some hormonal shifts appeared at the four-week mark, including reduced testosterone in women who drank caffeinated coffee.¹⁰ The results were mixed enough that the SHBG story, while compelling in observational data, has not been conclusively proven through experiments.

An earlier study in Japanese premenopausal women found that high intake of caffeinated beverages correlated with higher SHBG levels across the menstrual cycle, which the researchers described as a favorable shift for breast cancer risk.¹¹

Estrogen Metabolism and Racial Differences

The way coffee affects estrogen levels is not uniform across populations. A study following premenopausal women through their menstrual cycles found that white women consuming moderate caffeine had lower free estrogen, while Black and Asian women consuming similar amounts actually had higher free estrogen.¹² This racial divergence has not been fully explained, but it implies that the hormonal effects of coffee are not one-size-fits-all and could help explain some of the inconsistency across studies conducted in different populations.

Separately, research on estrogen metabolites found that women who drank four or more cups of coffee per day had significantly higher levels of certain estrogen breakdown products in their urine, particularly 2-hydroxyestradiol and 2-hydroxyestrone.¹³ These metabolites are sometimes considered “safer” estrogen forms because they have weaker estrogenic activity. Whether this shift in metabolism actually translates to reduced cancer risk in real life remains an open question.

Chlorogenic Acid in the Lab

Coffee is one of the richest dietary sources of chlorogenic acid, a polyphenol with antioxidant and anti-inflammatory properties. In laboratory and animal studies, chlorogenic acid has shown the ability to inhibit breast cancer cell growth, trigger cell death, and suppress the spread of cancer cells to other tissues. One study using a mouse model found that chlorogenic acid slowed tumor growth and improved survival in tumor-bearing mice, partly by boosting immune cell activity.¹⁴ These results are striking in the lab but should be treated cautiously. Cells in a dish and mice are not people, and the doses used in experiments often exceed what you would get from drinking coffee.

Genetics and Who Responds Differently

One of the most striking findings in this area involves women who carry BRCA1 mutations, which dramatically increase lifetime breast cancer risk. A study of BRCA1 carriers found that among women with a specific variant of the CYP1A2 gene (the enzyme primarily responsible for breaking down caffeine), coffee consumption was associated with a 64% reduction in breast cancer risk. Women with a different version of the same gene saw no benefit at all.¹⁵

The logic here is that people with the slower-metabolizing version of CYP1A2 keep caffeine and its metabolites circulating longer, which could amplify whatever protective effects those compounds have. This is one study, and it has not been replicated at scale in a way that would let clinicians make individual recommendations. But it illustrates why the population-wide average for coffee and breast cancer is so unremarkable: the average is probably a blend of people who benefit substantially and people who do not benefit at all, washing each other out.

The broader review of subgroups noted that the evidence for BRCA2 mutation carriers is much less clear, and additional research is needed before any conclusions can be drawn for that group.⁶

Coffee After a Breast Cancer Diagnosis

The question shifts once a woman has already been diagnosed with breast cancer. Here, some of the most intriguing findings involve tamoxifen, a widely prescribed drug for ER-positive breast cancer. A Swedish study found that patients with ER-positive tumors who were taking tamoxifen and drank two or more cups of coffee per day had a 60% lower risk of early cancer events compared to low-consumption patients.¹⁶

A further analysis of this relationship showed that the benefit was concentrated among normal-weight women. Among tamoxifen-treated, normal-weight patients with ER-positive tumors, those drinking two or more cups daily had a 63% lower risk of recurrence. Overweight and obese patients did not show the same pattern.¹⁷ The researchers linked this to lower insulin-like growth factor receptor levels in tumors of coffee-drinking patients, a potential mechanism for how coffee might enhance tamoxifen’s effectiveness.

Looking more broadly at cancer survival, a recent systematic review and meta-analysis covering multiple cancer types found that each additional cup of coffee or tea was associated with about a 7% reduction in breast cancer progression risk in dose-response models. However, when the authors separated coffee from tea for breast cancer specifically, only tea reached significance; coffee alone did not show a clear survival benefit in the pooled data.¹⁸ The tamoxifen-specific findings are more promising than the general survival data, which suggests the interaction with specific treatments may be where the real story lies.

Caffeinated Versus Decaffeinated

If caffeine is involved in the protective mechanisms, you would expect decaf to perform differently. A 22-year follow-up of nurses found no significant association between breast cancer risk and caffeinated coffee, decaffeinated coffee, or tea, though there was a slight trend toward lower risk with increasing caffeinated coffee consumption that fell short of significance.¹⁹ The NIH-AARP diet and health study, another large cohort, also found no evidence of a relationship with either caffeinated or decaffeinated coffee.²⁰

The SHBG data mentioned earlier provides one clue: caffeinated coffee raised SHBG levels in postmenopausal women while decaf did not, suggesting caffeine plays a role in that specific hormonal pathway.⁹ On the other hand, decaffeinated coffee still contains chlorogenic acid and other polyphenols, so it is not biologically inert. The mammographic density data even showed that decaf was inversely associated with breast density in postmenopausal women, a potentially favorable sign for cancer risk.²¹ The picture is genuinely mixed, and the honest answer is that neither caffeinated nor decaffeinated coffee has been convincingly shown to matter much in large, well-designed studies of overall breast cancer risk.

Mammographic Breast Density

Dense breast tissue, where a higher proportion of the breast is glandular and fibrous rather than fatty, is itself a risk factor for breast cancer. Some researchers have examined whether coffee intake affects density, since that could be one route through which coffee influences risk. The relationship turns out to be complicated and, once again, depends on menopausal status.

In premenopausal women, decaffeinated coffee was associated with higher breast density, which is the direction you would not want. In postmenopausal women, total coffee and decaffeinated coffee were associated with lower density, which is the direction you would want. Among women using hormone therapy, regular coffee and caffeine showed an inverse association with density.²¹ The divergence by menopausal status mirrors what we see in the cancer-outcome data, reinforcing the idea that whatever coffee is doing to breast tissue, hormonal context changes the direction of the effect.

Should You Worry About Acrylamide in Coffee?

Coffee roasting produces small amounts of acrylamide, a chemical classified as a probable human carcinogen based on animal studies. This has led to periodic headlines and even a lawsuit in California. But the epidemiological evidence does not support a connection between dietary acrylamide and breast cancer risk. A study of premenopausal women in the United States found no association between acrylamide intake from any food source, including coffee, and breast cancer risk.²² A Swedish prospective study of long-term dietary acrylamide intake reached the same conclusion, finding no link with breast cancer regardless of estrogen or progesterone receptor status.²³

The doses of acrylamide that cause cancer in lab animals are orders of magnitude higher than what anyone gets from their morning coffee. If there is a chemical in coffee to worry about with respect to breast cancer, the current evidence says acrylamide is not it.

What Brewing Method Might Mean

Most of the large studies do not distinguish between brewing methods, which is a limitation because the chemical profile of coffee changes dramatically depending on how it is prepared. Filtered coffee has lower levels of diterpene lipids like cafestol and kahweol, which are present in higher amounts in unfiltered methods like French press, espresso, and Scandinavian-style boiled coffee. These diterpenes have shown both pro- and anti-cancer properties in lab studies.

The Norwegian cohort study that separated brewing methods found that boiled coffee at four or more cups per day was associated with about a 48% lower risk of breast cancer compared to less than one cup per day, but the trend across doses was not statistically significant. Both boiled and filtered coffee showed reduced postmenopausal breast cancer risk, while both showed a possible increase in premenopausal risk.⁸ This is a single cohort, and the brewing-method analysis has not been widely replicated, so it would be premature to pick your pour-over specifically for breast cancer prevention. But it is a reminder that “coffee” is not a single standardized substance, and future research may need to account for preparation method to find clearer signals.